Adults aged 50 and older who receive two doses of the recombinant zoster vaccine have a 73% lower rate of herpes zoster ophthalmicus, a serious eye infection caused by the shingles virus, compared to...

Pro

Against

Evidence from Studies

Supporting (1)

Community contributions welcome

Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years

Cohort Study

Human

2025 Dec 24

Contradicting (0)

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years

Score: 59

DOI: 10.1093/cid/ciaf440